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Purpose or Objective: Microbeam Radiation Therapy (MRT) is 
a relatively new approach in radiation oncology exploiting 
the dose-volume effect by using orthovoltage X-rays on a 
microscopic scale [1]. Arrays of plane parallel beams of 
typically 50 µm width with spacings of a few hundred µm 
show extraordinary normal tissue sparing, while still being 
capable to ablate tumours in preclinical research [2].  
Organ motion has not been an issue in MRT, as long as 
preclinical research was carried out in small samples, such as 
cell cultures and rodents. The possible future treatment of 
human brain tumours using microbeam radiation however 
may be affected by cardio-synchronous tissue pulsation. This 
pulsation, with amplitudes in the order of 100 µm [3], 
induces translational movements of the brain tissue causing a 
blurring of the planned plane-parallel dose pattern of 
microbeams in case of extended exposure times. 
 
Material and Methods: A Monte Carlo study to quantify these 
effects was performed using the Geant4 toolkit. Dose was 
scored in a homogeneous cubic water phantom of 15 cm size 
on a grid with 5 µm resolution perpendicular to the beam. 
The sensitive volume was chosen to have an extension of 1 
mm along the beam direction in 20 mm depth from the 
surface, which corresponds to the reference dosimetry 
conditions in MRT. The relative statistical uncertainty of the 
dose (1 standard deviation) per voxel was between 1% and 
1.5% in the peak region and between 6% and 9% in the dose 
valley, depending on the evaluated beam configuration and 
could be further reduced by appropriate binning of the raw 
data. 
 
Results: Monte Carlo calculations for different geometrical 
microbeam configurations and employed dose rates revealed 
significant changes of the planned dose patterns when 
compared to the static case. The chosen quality indicators of 
our study like peak dose, peak-to-valley dose ratio (PVDR), 
microbeam width, spacing, and penumbra were observed to 
be highly degraded, e.g. the PVDR being reduced by up to 
35%. 
 
Conclusion: We have demonstrated that the effect of even 
small organ motions occurring at heart rate frequencies in 
the brain can only be tolerated at high dose rates of approx. 
10 Gy/s. For example, a dose rate of 12.3 kGy/s can be given 
as a threshold value if one wants to apply a high peak 
entrance dose of 300 Gy in 3 mm depth for 50 µm wide 
microbeams and a primary beam size of 500 µm 
perpendicular to the scan direction. For lower dose rates the 
observed deterioration of the microbeam dose patterns is 
likely to destroy the intended dose sparing effect for healthy 
tissues. 
For interlaced microbeam geometries an appropriate gating 
technique could be applied in the future based on the phase 
of the cardiac cycle. 
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Purpose or Objective: Deep-inspiration breath-hold (DIBH) 
mitigates the breathing motion, and thereby reduces the 
treated volume. This yields less dose to adjacent organs-at-
risk, and enables dose escalated radiotherapy of locally 
advanced non-small cell lung cancer (NSCLC) patients. 
However, DIBH can potentially introduce an extra uncertainty 
as reproducibility of DIBH can be affected by e.g. arching or 
unwanted motion during inspiration. This study was designed 
to investigate the feasibility and geometrical reproducibility 
of the anatomy, when utilizing DIBH in radiotherapy of locally 
advanced NSCLC patients. 
 
Material and Methods: Seventeen NSCLC patients scheduled 
for curative radiotherapy were enrolled. One 4DCT in free-
breathing (FB) and one 3DCT in DIBH, both with intravenous 
contrast, were acquired prior to (pre), in the middle of 
(mid), and after (post) the course of treatment. 
Furthermore, cone-beam CTs (CBCTs) both in FB and DIBH 
were acquired weekly throughout the course of treatment. A 
marker-based optical breathing signal (RPM, Varian Medical 
Systems, CA, USA) was utilized both for phase sorting into 10 
phases during 4DCT and for visual guidance in DIBH 
3DCT/CBCT. Changes in relative lung volumes (DIBH over FB) 
and in gross tumor volumes (GTVs) over the course of 
treatment were analyzed. Furthermore, the feasibility of 
DIBH for locally advanced NSCLC patients was analyzed based 
on the average breath-hold times and average number of 
breath-holds required to complete a CBCT acquisition. 
 
Results: Compared to FB, the total lung volume increased in 
DIBH by, on average, a factor of 1.84, 1.81 and 1.86 for the 
pre, mid and post treatment scans, respectively. A 
correlation between relative total lung volume (DIBH/FB) and 
mean amplitude during DIBH CT was observed (Figure 1). No 
statistically significant changes in lung volume during the 
courses of treatment were discovered. In the middle of the 
treatment course the GTV had decreased with 34 % and 26 %, 
while at the end of treatment the decrease from the original 
GTV was 42 % and 43 % for DIBH and FB, respectively. On 
average 2.1 breath-holds, with an average breath-hold time 
of 43 seconds, were required for a patient to complete a 
DIBH CBCT acquisition. However, among the patients this 
varied between 1 to 11 breath-holds with breath-hold times 
ranging from 4 to 74 seconds. For each patient, no 
statistically significant changes in breath-hold times or 
